BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 22522779)

  • 1. Allogeneic bone marrow grafts with high levels of CD4(+) CD25(+) FoxP3(+) T cells can lead to engraftment failure.
    Fricke S; Rothe K; Hilger N; Ackermann M; Oelkrug C; Fricke C; Schönfelder U; Niederwieser D; Emmrich F; Sack U
    Cytometry A; 2012 Jun; 81(6):476-88. PubMed ID: 22522779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.
    Schmidt F; Hilger N; Oelkrug C; Svanidze E; Ruschpler P; Eichler W; Boldt A; Emmrich F; Fricke S
    Cytometry A; 2015 Apr; 87(4):334-45. PubMed ID: 25717029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease.
    Sato K; Eizumi K; Fukaya T; Fujita S; Sato Y; Takagi H; Yamamoto M; Yamashita N; Hijikata A; Kitamura H; Ohara O; Yamasaki S; Saito T; Sato K
    Blood; 2009 May; 113(19):4780-9. PubMed ID: 19228924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells.
    Sefrioui H; Billiau AD; Overbergh L; Rutgeerts O; Waer M
    Transplantation; 1999 Nov; 68(10):1560-7. PubMed ID: 10589955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased incidence of murine graft-versus-host disease after allogeneic bone marrow transplantation by previous infusion of syngeneic bone marrow cells.
    Waer M; Ang KK; van der Schueren E; Vandeputte M
    Transplantation; 1984 Oct; 38(4):396-400. PubMed ID: 6238457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic non-adherent bone marrow cells facilitate hematopoietic recovery but do not lead to allogeneic engraftment.
    Fricke S; Ackermann M; Stolzing A; Schimmelpfennig C; Hilger N; Jahns J; Hildebrandt G; Emmrich F; Ruschpler P; Pösel C; Kamprad M; Sack U
    PLoS One; 2009 Jul; 4(7):e6157. PubMed ID: 19582154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recipient type-specific engineered regulatory T cells prevent graft-vs-host disease after allogeneic bone marrow transplantation in mice.
    Chen C; Cao J; Zeng L; Li Y; Wang D; Xu K
    Transplant Proc; 2011 Jun; 43(5):2041-8. PubMed ID: 21693322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of donor T(reg) cells on GVHD and hematopoietic reconstitution after allogeneic bone marrow transplantation in mice].
    Yang K; Liu QF; Fan ZP; Zhang Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):547-52. PubMed ID: 17605863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation.
    Bhattacharyya S; Cowan MJ
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):657-71. PubMed ID: 16125636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of allogeneic bone marrow and spleen cell transplantation in a murine model using ultraviolet-B light.
    Pamphilon DH; Alnaqdy AA; Godwin V; Preece AW; Wallington TB
    Blood; 1991 May; 77(9):2072-8. PubMed ID: 1826855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of Tripterygium hypoglaucum (level) Hutch extraction on regulatory T cells in mice after allogeneic bone marrow transplantation].
    Li S; Xu KL; Li ZY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Oct; 29(10):910-4. PubMed ID: 20073223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
    Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
    Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete allogeneic hematopoietic chimerism achieved by in utero hematopoietic cell transplantation and cotransplantation of LLME-treated, MHC-sensitized donor lymphocytes.
    Hayashi S; Hsieh M; Peranteau WH; Ashizuka S; Flake AW
    Exp Hematol; 2004 Mar; 32(3):290-9. PubMed ID: 15003315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation.
    Hanash AM; Levy RB
    Blood; 2005 Feb; 105(4):1828-36. PubMed ID: 15494429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flt3-L augments the engraftment of donor-derived bone marrow cells when combined with sublethal irradiation and costimulatory (CD28/B7 and CD40/CD40L) blockade.
    Woodward JE; Salam A; Logar AJ; Schaefer AT; Rao AS
    Cell Transplant; 2002; 11(2):147-59. PubMed ID: 12099638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recipient-Derived Allo-iTregs Induced by Donor DCs Effectively Inhibit the Proliferation of Donor T Cells and Reduce GVHD.
    Yang ZG; Wen RT; Feng JS; Cao PJ; Zhou HT; Liu WX
    Anat Rec (Hoboken); 2019 May; 302(5):825-836. PubMed ID: 30312018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
    Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
    Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.